Patent · US Active

Modified nucleotides

US8536323B2 · kind B2 · utility

4Cited by

22References

20Claims

0Family size

Assignee

Pierce Biotechnology, Inc. · US

Inventors

Kay Opperman · Oregon, US
Barbara J. Kaboord · Oregon, US
Jean-Samuel Schultz · Rockford, US
Christopher L. Etienne · Fitchburg, US
Greg Hermanson · Loves Park, US

Key dates

Filing date	Apr 20, 2011
Grant date	Sep 17, 2013
Priority date	—
Expiry date	Jan 25, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/143333
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.